HPLC and TLC methodology for determination or purity evaluation of 4-methoxy-2-(3(4-phenyl-1-piperazinyl))propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine. | Acta Pol Pharm;62(1): 3-10, 2005. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

HPLC and TLC methodology for determination or purity evaluation of 4-methoxy-2-(3(4-phenyl-1-piperazinyl))propyl-2,3-dihydro-6-methyl-1,3-dioxo-1H-pyrrolo[3,4-c]pyridine.

Muszalska, Izabela; Sladowska, Helena; Sabiniarz, Aleksandra.

Affiliation

Muszalska I; Department of Pharmaceutical Chemistry, Poznan University of Medical Sciences, 6 Grunwaldzka Str., 60-780 Poznan, Poland. imuszals@amp.edu.pl

Acta Pol Pharm ; 62(1): 3-10, 2005.

Article in En | MEDLINE | ID: mdl-16022487

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyridines / Analgesics Language: En Journal: Acta Pol Pharm Year: 2005 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyridines / Analgesics Language: En Journal: Acta Pol Pharm Year: 2005 Document type: Article Affiliation country: Country of publication: